APA (7th ed.) Citation

Fang, R., Jia, Z., Xin, Y., Zhao, K., Qin, W., Lu, H., . . . Fang, H. N6-methyladenosine-modification of USP15 regulates chemotherapy resistance by inhibiting LGALS3 ubiquitin-mediated degradation via AKT/mTOR signaling activation pathway in hepatocellular carcinoma. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Fang, Ronghuan, Zhigang Jia, Yuhang Xin, Kai Zhao, Wei Qin, Haoran Lu, Yi Zhou, Yongsheng Yang, and He Fang. N6-methyladenosine-modification of USP15 Regulates Chemotherapy Resistance by Inhibiting LGALS3 Ubiquitin-mediated Degradation via AKT/mTOR Signaling Activation Pathway in Hepatocellular Carcinoma. Nature Publishing Group.

MLA (9th ed.) Citation

Fang, Ronghuan, et al. N6-methyladenosine-modification of USP15 Regulates Chemotherapy Resistance by Inhibiting LGALS3 Ubiquitin-mediated Degradation via AKT/mTOR Signaling Activation Pathway in Hepatocellular Carcinoma. Nature Publishing Group.